Fred Alger Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Fred Alger Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-50,000	Closed	-$305K	–	535
2020 Q2	$305K	Hold	50,000	–	–	﹤0.01%	416
2020 Q1	$114K	Hold	50,000	–	–	﹤0.01%	407
2019 Q4	$230K	Buy	+50,000	New	+$198K	﹤0.01%	408
2019 Q2	–	Sell	-45,000	Closed	-$603K	–	575
2019 Q1	$603K	Buy	+45,000	New	+$513K	﹤0.01%	359
2018 Q2	–	Sell	-14,000	Closed	-$241K	–	608
2018 Q1	$241K	Hold	14,000	–	–	﹤0.01%	395
2017 Q4	$307K	Sell	14,000 -4,000	-22%	-$129K	﹤0.01%	398
2017 Q3	$736K	Buy	18,000 +3,000	+20%	+$94.2K	﹤0.01%	339
2017 Q2	$452K	Buy	15,000 +3,000	+25%	+$93.6K	﹤0.01%	368
2017 Q1	$434K	Sell	12,000 -3,000	-20%	-$132K	﹤0.01%	366
2016 Q4	$752K	Hold	15,000	–	–	﹤0.01%	310
2016 Q3	$787K	Buy	15,000 +600	+4%	+$28.7K	﹤0.01%	322
2016 Q2	$595K	Hold	14,400	–	–	﹤0.01%	368
2016 Q1	$585K	Sell	14,400 -7,150	-33%	-$246K	﹤0.01%	406
2015 Q4	$894K	Buy	+21,550	New	+$722K	﹤0.01%	392

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Fred Alger Management's FPRX Position: Q3 2020 in Review

Fred Alger Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2020, closing a stake of 50,000 shares — an estimated $305K sold.

Fred Alger Management first reported a position in FPRX in Q4 2015 and held it in 14 quarters. The position peaked at $894K in Q4 2015. 94 funds tracked by Wall St. Rank hold FPRX as of Q3 2020.

Fred Alger Management reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
Fred Alger Management sold 50,000 Five Prime Therapeutics, Inc. shares in Q3 2020, an estimated $305K.
Fred Alger Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 14 quarters.
Fred Alger Management's Five Prime Therapeutics, Inc. position peaked at $894K in Q4 2015.
94 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2020.

Based on Fred Alger Management's 13F filing for Q3 2020, filed 13 Nov 2020.